Skip to content

Ayurvedic Treatment for Primary Dysmenorrhea Kashtartava

COMPARATIVE CLINICAL STUDY OF MENOCRAMP TABLET AND SAPTASARAM GHAN VATI IN THE MANAGEMENT OF KASHTARATVA (PRIMARY DYSMENORRHEA)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/041911
Enrollment
150
Registered
2022-04-19
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Sponsors

Solumiks Herbaceuticals Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women between the age group 15 to 30 years. 2. Women with regular cycle with painful menstruation. 3. Women without any pelvic pathology. 4. Be able and willing in the view of the investigator to comply with all study procedures and sign informed written consent form.

Exclusion criteria

Exclusion criteria: Women with history of PID endometriosis and debilitating pathological conditions of the pelvic organs, systemic diseases like diabetes mellitus bronchial asthma tuberculosis thyroid dysfunction with organic lesion benign or malignant growth of reproductive tract uterine prolapse and Hypo-plastic uterus Women with congenital anomalies of genital organs Polycystic ovarian disease Patients with chronic hepatic neurological or orthopedic conditions neuropsychiatric illness malignancy or AIDS Subjects rejecting to sign the consent form drug addicts Patients with clinically significant cardiovascular, hematological, pancreatic metabolic neurological disorders or clinically significant laboratory abnormalities which in the judgement of the investigator would interfere with the subjects participation in the study or evaluation of the subjects response to therapy

Design outcomes

Primary

MeasureTime frame
pain relief relief in associated complaintsTimepoint: 1 month with 1 month follow up

Secondary

MeasureTime frame
psychological relief and improvement in QoL of participantsTimepoint: 1 month during study and during follow up period

Countries

India

Contacts

Public ContactDr Asokan V

Parul Institute of Ayurveda, Parul University

drasokan24@gmail.com6361740431

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026